Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Diane Meitzner
Introduction
Diane Meitzner is a notable inventor based in Wolfen, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of periodontal diseases. Her work focuses on developing novel compounds that can inhibit bacterial glutaminyl cyclases, which are crucial in addressing various dental health issues.
Latest Patents
Diane Meitzner holds a patent for her invention titled "Inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodontal and related diseases." This patent encompasses innovative compounds that serve as inhibitors of bacterial glutaminyl cyclases (bacQC). The invention includes pharmaceutical compositions that utilize these compounds for treating periodontitis and related conditions. Additionally, it outlines methods for identifying candidate compounds that may interact with the binding pocket of bacQC and act as effective inhibitors.
Career Highlights
Diane is associated with the Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung E.V., a leading research organization in Germany. Her work at this institution has allowed her to contribute to advancements in medical research and pharmaceutical development.
Collaborations
Diane collaborates with esteemed colleagues, including Christian Jäger and Linda Liebe. Their combined expertise enhances the research and development efforts in their field.
Conclusion
Diane Meitzner's innovative work in developing inhibitors for bacterial glutaminyl cyclases represents a significant advancement in the treatment of periodontal diseases. Her contributions continue to impact the pharmaceutical industry positively.